These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 34140468)

  • 1. CRISPR-Associated Primase-Polymerases are implicated in prokaryotic CRISPR-Cas adaptation.
    Zabrady K; Zabrady M; Kolesar P; Li AWH; Doherty AJ
    Nat Commun; 2021 Jun; 12(1):3690. PubMed ID: 34140468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cas1 and Cas2 From the Type II-C CRISPR-Cas System of
    He Y; Wang M; Liu M; Huang L; Liu C; Zhang X; Yi H; Cheng A; Zhu D; Yang Q; Wu Y; Zhao X; Chen S; Jia R; Zhang S; Liu Y; Yu Y; Zhang L
    Front Cell Infect Microbiol; 2018; 8():195. PubMed ID: 29951376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How type II CRISPR-Cas establish immunity through Cas1-Cas2-mediated spacer integration.
    Xiao Y; Ng S; Nam KH; Ke A
    Nature; 2017 Oct; 550(7674):137-141. PubMed ID: 28869593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Casposons: a new superfamily of self-synthesizing DNA transposons at the origin of prokaryotic CRISPR-Cas immunity.
    Krupovic M; Makarova KS; Forterre P; Prangishvili D; Koonin EV
    BMC Biol; 2014 May; 12():36. PubMed ID: 24884953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fidelity of prespacer capture and processing is governed by the PAM-mediated interactions of Cas1-2 adaptation complex in CRISPR-Cas type I-E system.
    Yoganand KN; Muralidharan M; Nimkar S; Anand B
    J Biol Chem; 2019 Dec; 294(52):20039-20053. PubMed ID: 31748409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cas1-Cas2 complex formation mediates spacer acquisition during CRISPR-Cas adaptive immunity.
    Nuñez JK; Kranzusch PJ; Noeske J; Wright AV; Davies CW; Doudna JA
    Nat Struct Mol Biol; 2014 Jun; 21(6):528-34. PubMed ID: 24793649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural plasticity and in vivo activity of Cas1 from the type I-F CRISPR-Cas system.
    Wilkinson ME; Nakatani Y; Staals RH; Kieper SN; Opel-Reading HK; McKenzie RE; Fineran PC; Krause KL
    Biochem J; 2016 Apr; 473(8):1063-72. PubMed ID: 26929403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR adaptation from a structural perspective.
    Sasnauskas G; Siksnys V
    Curr Opin Struct Biol; 2020 Dec; 65():17-25. PubMed ID: 32570107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR type II-A subgroups exhibit phylogenetically distinct mechanisms for prespacer insertion.
    Van Orden MJ; Newsom S; Rajan R
    J Biol Chem; 2020 Aug; 295(32):10956-10968. PubMed ID: 32513871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Foreign DNA acquisition by the I-F CRISPR-Cas system requires all components of the interference machinery.
    Vorontsova D; Datsenko KA; Medvedeva S; Bondy-Denomy J; Savitskaya EE; Pougach K; Logacheva M; Wiedenheft B; Davidson AR; Severinov K; Semenova E
    Nucleic Acids Res; 2015 Dec; 43(22):10848-60. PubMed ID: 26586803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-Cas adaptation in Escherichia coli requires RecBCD helicase but not nuclease activity, is independent of homologous recombination, and is antagonized by 5' ssDNA exonucleases.
    Radovcic M; Killelea T; Savitskaya E; Wettstein L; Bolt EL; Ivancic-Bace I
    Nucleic Acids Res; 2018 Nov; 46(19):10173-10183. PubMed ID: 30189098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primase-polymerases: how to make a primer from scratch.
    Bainbridge LJ; Zabrady K; Doherty AJ
    Biosci Rep; 2023 Jul; 43(7):. PubMed ID: 37358261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spacer-length DNA intermediates are associated with Cas1 in cells undergoing primed CRISPR adaptation.
    Musharova O; Klimuk E; Datsenko KA; Metlitskaya A; Logacheva M; Semenova E; Severinov K; Savitskaya E
    Nucleic Acids Res; 2017 Apr; 45(6):3297-3307. PubMed ID: 28204574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Cas adaptation in Escherichia coli.
    Mitić D; Bolt EL; Ivančić-Baće I
    Biosci Rep; 2023 Mar; 43(3):. PubMed ID: 36809461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interference-driven spacer acquisition is dominant over naive and primed adaptation in a native CRISPR-Cas system.
    Staals RH; Jackson SA; Biswas A; Brouns SJ; Brown CM; Fineran PC
    Nat Commun; 2016 Oct; 7():12853. PubMed ID: 27694798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cas1-Cas2 physically and functionally interacts with DnaK to modulate CRISPR Adaptation.
    Killelea T; Dimude JU; He L; Stewart AL; Kemm FE; Radovčić M; Ivančić-Baće I; Rudolph CJ; Bolt EL
    Nucleic Acids Res; 2023 Jul; 51(13):6914-6926. PubMed ID: 37264902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different genome stability proteins underpin primed and naïve adaptation in E. coli CRISPR-Cas immunity.
    Ivančić-Baće I; Cass SD; Wearne SJ; Bolt EL
    Nucleic Acids Res; 2015 Dec; 43(22):10821-30. PubMed ID: 26578567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the Origin of Reverse Transcriptase-Using CRISPR-Cas Systems and Their Hyperdiverse, Enigmatic Spacer Repertoires.
    Silas S; Makarova KS; Shmakov S; Páez-Espino D; Mohr G; Liu Y; Davison M; Roux S; Krishnamurthy SR; Fu BXH; Hansen LL; Wang D; Sullivan MB; Millard A; Clokie MR; Bhaya D; Lambowitz AM; Kyrpides NC; Koonin EV; Fire AZ
    mBio; 2017 Jul; 8(4):. PubMed ID: 28698278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spacer capture and integration by a type I-F Cas1-Cas2-3 CRISPR adaptation complex.
    Fagerlund RD; Wilkinson ME; Klykov O; Barendregt A; Pearce FG; Kieper SN; Maxwell HWR; Capolupo A; Heck AJR; Krause KL; Bostina M; Scheltema RA; Staals RHJ; Fineran PC
    Proc Natl Acad Sci U S A; 2017 Jun; 114(26):E5122-E5128. PubMed ID: 28611213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DnaQ exonuclease-like domain of Cas2 promotes spacer integration in a type I-E CRISPR-Cas system.
    Drabavicius G; Sinkunas T; Silanskas A; Gasiunas G; Venclovas Č; Siksnys V
    EMBO Rep; 2018 Jul; 19(7):. PubMed ID: 29891635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.